Duncan Williams Asset Management, LLC

Position in RLAY — Relay Therapeutics, Inc.

CIK 2011771 MEMPHIS, TN

Position in RLAY

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$259,619

+$145,811 QoQ

Shares Held

13,876

+21.3% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#176

of 256 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Duncan Williams Asset Management, LLC holds $2,085,826 across 5 Biotechnology names. RLAY ranks #4 (12.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRTA	Prothena Corp Public Ltd Co	70,281	$688,050
2	ZYME	Zymeworks Inc.	22,095	$577,563
3	ANAB	Anaptysbio, Inc	6,525	$440,437
4	RLAY	Relay Therapeutics, Inc. This page	13,876	$259,619
5	TVRD	Tvardi Therapeutics, Inc.	63,241	$120,157

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$259,619	13,876	+21.3%	Shares	Sole	2026-07-22
2026-03-31	$113,808	11,438	-2.8%	Shares	Sole	2026-05-05
2025-12-31	$99,514	11,763	—	Shares	Sole	2026-02-05
No filing history on record for this holder in this stock.